Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples